Table 1.
Baseline socio‐demographic and clinical characteristics of adolescents and young adults enrolled in HIV care and treatment clinics
| Characteristics | Adolescents | Young adults |
|---|---|---|
| Total N = 15,874 | N = 4961 | N = 10,913 |
| Age (median, IQR) | 18.1 [15.5–19.2] | 22.2 [21.1–23.2] |
| Sex, number (%) | ||
| Male | 1118 (22.5) | 1396 (12.8) |
| Female | 3843 (77.5) | 9517 (87.2) |
| Facility type, number (%) | ||
| Public | 4037 (77.6) | 9122 (79.6) |
| Private | 924 (22.4) | 1791 (20.4) |
| Regimen combination, number (%) | ||
| Dolutegravir based | 201 (4.1) | 559 (5.1) |
| Efavirenz based | 4182 (84.3) | 10,274 (94.1) |
| Nevirapine based | 524 (10.6) | 69 (0.6) |
| Protease inhibitor based | 45 (0.9) | 3 (0.03) |
| Others | 9 (0.2) | 8 (0.1) |
| WHO Stage, number (%) | ||
| WHO Stage 1 | 3025 (61.1) | 8104 (74.4) |
| WHO Stage 2 | 1028 (20.8) | 1605 (14.8) |
| WHO Stage 3 | 827 (16.7) | 1101 (10.1) |
| WHO Stage 4 | 68 (1.4) | 78 (0.7) |
| Missing | 13 (0.3) | 25 (0.2) |
| CD4 count in cells/mm3, number (%) | ||
| < 200 | 340 (6.9) | 541 (4.9) |
| 200–349 | 360 (7.3) | 845 (7.7) |
| 350–500 | 429 (8.7) | 951 (8.7) |
| > 500 | 730 (14.7) | 1646 (15.1) |
| Missing | 3102 (62.5) | 6930 (63.5) |
| Viral load at 6 months, number (%) | ||
| Suppressed | 1668 (33.6) | 3716 (34.1) |
| Not suppressed | 455 (9.2) | 502 (4.6) |
| Missing | 2838 (57.2) | 6695 (61.4) |
| BMI (kg/m2) categories, number (%) | ||
| BMI <18.5 (underweight) | 833 (16.8) | 882 (8.1) |
| 18.5 ≤ BMI < 24 (normal) | 2225 (44.9) | 5684 (52.1) |
| 24 ≤ BMI < 27 (overweight) | 538 (10.8) | 1873 (17.2) |
| BMI ≥ 27 (obese) | 149 (3.0) | 703 (6.4) |
| Missing | 1216 (24.5) | 1771 (16.2) |
| TB status at enrolment, number (%) | ||
| TB co‐infection | 40 (0.8) | 64 (0.6) |
| No TB co‐infection | 4921 (99.2) | 10,849 (99.4) |
| Year started ART | ||
| 2015 | 466 (9.4) | 957 (8.8) |
| 2016 | 742 (15.0) | 1444 (13.2) |
| 2017 | 1493 (30.1) | 2905 (26.6) |
| 2018 | 1184 (23.9) | 2660 (24.4) |
| 2019 | 1076 (21.7) | 2947 (27.0) |
Abbreviations: BMI, body mass index; IQR, interquartile range; TB, tuberculosis; WHO, World Health Organization.